Brain Injury & Micro Current Neurofeedback Research Study
IASIS MCN works on two pathways to promote relaxation and optimize brain function. Firstly, it alleviates the flight or fight response, inducing a profound state of relaxation for enhanced neuroregulation. Additionally, it facilitates the detoxification process within the brain. IASIS MCN neurofeedback is the fastest device on the market for neurofeedback. Clients can experience swifter results and stay at the forefront of long-lasting sustainability with little to no observed reactivity.
Latest Finding on Micro Current Neurofeedback Will Astound You
New research reveals that IASIS MCN neurofeedback has a promising success rate of 95% (P=95). This means that 95% of neurofeedback sessions will yield the desired results. Furthermore, no adverse side effects have been reported out of the 2 million IASIS MCN neurofeedback sessions conducted worldwide.
During neuroregulation, it is not uncommon for individuals to experience a slight and temporary increase in their perceived symptoms. This is a natural part of the neuroregulation process, as it aids in shifting individuals out of a state known as “dorsal vagal freeze.” It ultimately helps the brain and nervous system heal themselves.
Micro Current Neurofeedback Publised Papers & studies
Discover the compelling evidence behind the effectiveness of IASIS MCN neurofeedback. Backed by three credible studies, including two prestigious University publications and a white paper from the leading European biofeedback Institute.
“Passive Neurofeedback Treatments for Mild Traumatic Brain Injury: Neuroimaging Changes Detected by MEG after applying Low-Intensity Pulses using Transcranial Electrical Stimulation”
Ming-Xiong Huang,1,2* Ashley Robb Swan,1,2 Annemarie Angeles Quinto,1,2 Scott Matthews,3,4 Deborah L. Harrington,1,2 Sharon Nichols,5 Barry J. Bruder,6 Corey C. Snook,6 Charles W. Huang,7 Dewleen G. Baker,2,8,9 Roland R. Lee1,2
“The effectiveness of microcurrent neurofeedback on depression, anxiety, post-traumatic stress disorder, and quality of life”
Duke, Gloria PhD, RN (Professor)1; Yotter, Courtney N. MS, CCRP, PMP (Statistical Consultant)2; Sharifian, Beverly MS, APCC (Associate Professional Clinical Counselor and Psychometrist)3; Duke, Gary MA, LPC (Counselor, IASIS Microcurrent Neurofeedback Practitioner)4; Petersen, Sandra DNP, APRN, FNP-BD, GNP-BC, PMHNP-BE, FAANP (Professor)5
“INTEGRATION OF MICROCURRENT NEUROFEEDBACK IN CLINICAL BIO- AND NEUROFEEDBACK PRACTICE”
Dr. oec. Eva Otzen-Wehmeyer
Director of the Institute for Neurofeedback and Biofeedback
The Micro Current Neurofeedback Revolution is just begining
Currently, extensive research and self-analysis of patients are being conducted across 50 clinics worldwide. IASIS Tech has launched a powerful app that collects data from anonymous patients worldwide. This highly secure and encrypted data will be used for impactful research and advanced analytics. IASIS Tech is working on advanced technology that integrates HRV (Heart Rate Variability) to offer real-time proof of immediate nervous system support during an IASIS MCN session. We are in communication with the Veterans Administration and NFL to conduct research studies. In addition, we have partnered with various organizations worldwide that are researching IASIS MCN and Autism Spectrum Disorders (ASD).
Brain Injury & Micro Current Neurofeedback Research Study
A Pilot Treatment Study for Mild Traumatic Brain Injury: Neuroimaging Changes Detected by Meg After Low-Intensity Pulse-Based Transcranial Electrical Stimulation.
Mild traumatic brain injury (mTBI) is a leading cause of sustained impairments in military service members, Veterans, and civilians. However, few treatments are available for mTBI, partially because the mechanism of persistent mTBI deficits is not fully understood.
To view the entire Pilot Treatment Study for Mild Traumatic Brain Injury in PDF file format, contact us for more neurofeedback research using the button below or call (951) 894-1045.
Diedrich Klinghardt, MD, Functional Medicine Brain Expert Interviews Barry Bruder of IASIS Micro Current Neurofeedback
August 29, Dr. Diedrich Klinghart hosts his Brain Symposium with an expected 300 Physician members of the Klinghardt Institute this year held in Freiburg, Germany. Klinghardt invited Barry Bruder to open the conference presenting on IASIS Technologies Micro Current Neurofeedback research now in year three of a federally funded double blind study with the University of California San Diego and the Veterans Administration. Due to Covid-19, the presentation has been recorded, and will be presented in Germany to open the conference despite the restrictions on travel. IASIS Tech is grateful to have their EU team from Montreux, Switzerland, Eva and Jöerg Otzen represents IASIS MCN at the neurofeedback research conference.
IASIS Micro Current Neurofeedback FAQs
Yes, years of neurofeedback research indicates it’s extremely safe. There has not been a single reported case of someone being worse off from being treated with MCN Micro Current Neurofeedback.
In the first few MCN Micro Current Neurofeedback sessions, a client sometimes experiences temporary fatigue, “light headedness” or a feeling of being “revved up.” Mild headaches also occasionally occur. These symptoms are always temporary, and typically last only a few minutes to a few hours.
MCN Micro Current Neurofeedback is very effective in many areas, including:
Post Traumatic Stress Disorder – MCN Micro Current Neurofeedback is exceptionally effective at reducing Post Traumatic Stress Disorder (PTSD) and other forms anxiety. Ninety percent of clients begin to experience improvement in the first or second session. MCN Micro Current Neurofeedback also improves resilience, the ability to handle stress, and helps create a sense of calm in difficult situations.
Traumatic Brain Injury (TBI) – In mild and moderate TBI, clarity, concentration, memory, multi-tasking and energy consistently and rapidly improve.
ADD/ADHD – MCN Micro Current Neurofeedback decreases impulsivity, distractibility and hyperactivity. The world becomes easier to navigate. Life becomes less of a struggle.
Substance Abuse – Because MCN Micro Current Neurofeedback is so effective at treating anxiety, depression and poor impulse control, it can be tremendously helpful for people withdrawing from and staying away from addictive substances. MCN Neurofeedback is now being used at many recovery centers.
Most people notice initial changes within three sessions, occasionally a few more. The average number of sessions varies depending on the acuity of one’s condition. Once treatment has been completed, additional sessions are usually not necessary. Occasionally individuals may require a “booster.”
The success rate is staggering. Over 85% of clients claim by their own assessment that they experience significant, often dramatic, benefits. With traumatic brain injury, clarity begins to return, headaches and migraines diminish. The “fog” begins to lift and cognitive function begins to return. In PTSD, anxiety starts to abate, panic attacks stop, sleep improves and depression lifts. And the changes are enduring. Once enough sessions have been completed, assisting the recipient to get closer, treatment is usually done.
No. Medication does not diminish the effectiveness of IASIS MCN Micro Current Neurofeedback. There is no need to stop or reduce your medication, which should only be done in conjunction with your healthcare provider once MCN treatment is complete.
MCN uses a very low power (3 pico or 3 trillionths of a watt) electromagnetic field to carry feedback to the person receiving it. The feedback travels down the same wires carrying the brain waves to the amplifier and computer.
Although the MCN signal is weak, it produces a measurable change in the brainwaves without conscious effort from the individual receiving the feedback. This feedback frequency correlates with the dominant brainwave frequency. When exposed to this feedback frequency, the EEG amplitude distribution changes in power. The result is a changed brainwave state and much greater ability for the brain and nervous system to regulate itself.
MCN is a direct feedback, imperceptible to the client, and requiring no conscious effort. Although, like many pharmaceuticals, MCN is not yet completely understood, at the very least the sympathetic and parasympathetic nervous systems are profoundly influenced as is the central nervous systems. Brain chemistry is affected in ways that still need to be elucidated.
In traditional neurofeedback, information from your brainwaves is transmitted to a computer screen. Clients attempt to train their brainwaves by mentally manipulating events on the screen. No signal is transmitted back to the brain. This kind of neurofeedback typically requires 40+ sessions, with a typical session lasting 45 minutes to an hour.
With MCN Micro Current Neurofeedback clients don’t do anything other than sit still for a few moments. A brief, tiny signal transmitted feeding back to the brain does all the work. And unlike traditional neurofeedback clients, MCN Micro Current Neurofeedback clients generally notice changes either immediately or within the first few sessions. Fast action, limited number of sessions, and the ease and simplicity of treatment all distinguish MCN Micro Current Neurofeedback from traditional neurofeedback.
Practitioners have used earlier and similar versions of MCN Micro Current Neurofeedback for over 15 years. MCN Micro Current Neurofeedback is not experimental. Over 75,000 patients have been treated with technologies similar in principle to IASIS MCN Micro Current Neurofeedback.
Only frozen, stuck patterns are affected. Healthy, functional brainwave patterns are flexible and resilient. When there is a tiny fluctuation they automatically spring back to their healthy patterns.
No. IASIS MCN is only to be administered to patients by trained doctors and clinicians. It is not intended for home use.
DISCLAIMER: This website does not contain medical advice. IASIS MCN is not a medical treatment, rather the retraining of the brain and nervous system. The information, including but not limited to text, videos, images and other material contained on this website is for informational purposes only. The purpose of this website is to promote broad consumer understanding and knowledge about IASIS MCN. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. If you believe you have a medical condition, please first, always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. Video and written success stories contained on this site are the sole experience of those individuals shown or having written them, and are not the opinions of IASIS Technologies, Inc. Never self-medicate or choose to discontinue taking medicine without discussing your medical care with your doctor.